Program Overview:
Bioscience companies rely more heavily on having an effective intellectual property portfolio than do companies based on other technologies. Often, the time required to reach product commercialization in biosciences is several years in the future. As a result, one of the greatest assets for the company is its intellectual property portfolio. Both a sword and a shield, a strong portfolio enables the company to protect the promise that it will be able to maintain a proprietary position in the market relative to its competitors. As a result of its pivotal role in the future success of the bioscience company, the presence of an effective portfolio is key to attracting potential investors.

This workshop will cover basic elements involved in developing a commercially meaningful intellectual property portfolio for a bioscience company. Topics that will be discussed include identifying and protecting bioscience inventions, as well as decision making in developing, managing and investing in the portfolio.

Benefits of Attending:

• Effects of recent court decisions on the patentability of genetic material and diagnostic techniques
• How to identify protectable bioscience inventions
• The types of hurdles that must be cleared in obtaining meaningful patent protection
• Strategic use of intellectual property
• Biosimilars
• Generic competition

A light lunch will follow the workshop for further questions and discussion for interested parties.

Who should attend:
This workshop is reserved for Founders, CEO’s, Entrepreneurs, Managers, Researchers, VCs, Business Development Professionals, and Scientists, ONLY.  Please, no competing law firms.